Held in partnership with the University of Edinburgh and the Journal of Parkinson’s Disease, with Edinburgh University’s Professor Tilo Kunath as chair, the next edition in our quarterly webinar series will take place on Wednesday 29th January 2025 at 5pm.

Robust, high-quality clinical trials can take years to lead to results. To help address this, researchers have been devising methods to speed up the clinical trial process to accelerate the development and progression of potential treatments. This hour-long webinar will focus on multi-arm, multi-stage (MAMS) clinical trial platforms and how researchers are using these to test multiple therapies simultaneously.

Discussion will focus around:

  • The background and rationale for using MAMS platforms.
  • Learnings from MAMS projects in Parkinson’s and other conditions.
  • Ongoing initiatives for Parkinson’s in the UK and abroad.

Details

Date
Wednesday 29th January 2025
Cost
Free
Type
Cure Parkinson’s Event
Book your place

Meet our panelists

Georgia Mills is the Research Project Manager for EJS ACT-PD, an upcoming MAMS platform for Parkinson’s in the UK, at University College London (UCL). Georgia leads and coordinates much of the trial operations and helps to oversee the seven key consortium working groups.

Professor Charalampos (Haris) Tzoulis is a Professor of Neurology and Neurogenetics in the Department of Clinical Medicine at the University of Bergen (UIB) and Haukeland University Hospital. His research focus is on exploring the role of mitochondrial dysfunction in Parkinson’s and the development of neuroprotective therapies. He is currently working to set-up the SLEIPNIR study, a MAMS de-risking platform in Norway.

Dr Emma Gray, PhD, is the Director of Research at the MS Society. Previously, Dr Gray worked at the MRC Centre for Neurodegeneration Research at King’s College London. Dr Gray and the MS Society have been fundamental in the ongoing Octopus trial: the first ever MAMS platform for progressive Multiple Sclerosis (MS). Based in the UK and run by a research team at UCL, this platform launched in April 2023 with the aim of finding treatments able to slow down disability progression in people with MS.

Kuhan Pushparatnam is a Parkinson’s advocate and member of EJS ACT-PD’s Patient and Public Involvement and Engagement (PPIE) working group. Diagnosed with young onset Parkinson’s at age 38, Kuhan now uses his experiences to help others. He is the co-host with Dave Clark of the ongoing podcast “2 Parkie’s in a Pod“. Kuhan has also recently developed the Parkinson’s ON app, which aims to help people with Parkinson’s better manage the condition.

If you would like to keep up to date with all our future webinars along with our latest research and fundraising news make sure to sign up to our newsletter.

Sign up to our E-Newsletter